Zonisamide and Linagliptin Interaction
Drug interaction information between Zonisamide and Linagliptin.
Zonisamide and Linagliptin have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Zonisamide and Linagliptin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.
How They Interact
Zonisamide can lower the level of bicarbonate in your blood, which makes your blood more acidic. This increases the risk of metabolic acidosis when combined with this diabetes medication.
Zonisamide Also Interacts With
- Alogliptin moderate
- Ertugliflozin moderate
- Topiramate moderate
- Carbamazepine minor
- Empagliflozin minor
Linagliptin Also Interacts With
- Metformin moderate
- Dolutegravir moderate
- Ranolazine moderate
- Cimetidine moderate
- Topiramate minor
Frequently Asked Questions
What SPL severity band is on file for Zonisamide + Linagliptin?
Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.
Which drug in this pair has the larger labeled-interaction portfolio?
Zonisamide has 13 labeled pairs on file vs Linagliptin's 9. In the minor band specifically: Zonisamide has 10 (also Carbamazepine, Empagliflozin, Empagliflozin/Linagliptin, Metformin); Linagliptin has 5 (also Topiramate, Rifampin, Phenytoin, Empagliflozin/Linagliptin).
What mechanism field is on file for Zonisamide and Linagliptin?
Zonisamide can lower the level of bicarbonate in your blood, which makes your blood more acidic. This increases the risk of metabolic acidosis when combined with this diabetes medication.
Zonisamide's labeled portfolio outnumbers Linagliptin
SPL source-record counts only. This page's band is minor · classes on file: Zonisamide (Anticonvulsant (Sulfonamide)); Linagliptin (DPP-4 Inhibitor).
0 major · 3 moderate · 10 minor · 13 total
- Other minor peers for Zonisamide
- Carbamazepine
- Empagliflozin
- Empagliflozin/Linagliptin
- Metformin
0 major · 4 moderate · 5 minor · 9 total
- Other minor peers for Linagliptin
- Topiramate
- Rifampin
- Phenytoin
- Empagliflozin/Linagliptin
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.
Read our methodology - how this data is sourced, computed, and verified.